Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pediatric Neurology

Developmental Support & Managing Comorbidities

At a Glance

Children with CNTNAP2-related DEE benefit from a coordinated care plan beyond seizure management, including early communication support, physical and occupational therapy, and regular attention to sleep, feeding, swallowing, digestion, safety, and caregiver well-being.

Caring for a child with CNTNAP2-related DEE requires looking far beyond the seizure count. Because this condition impacts the brain’s development from the start, your child needs a “whole-person” approach that supports their ability to communicate, move, and thrive in daily life [1][2]. This strategy is often called etiology-informed care, meaning the treatment is tailored to the specific genetic cause and its unique challenges [3].

Building Your Multidisciplinary Care Team

No single doctor can manage all the complexities of this condition. A coordinated team helps ensure that all aspects of your child’s health are monitored [1][4].

  • Medical Specialists: This typically includes a pediatric neurologist (for seizure management), a clinical geneticist (to interpret genetic updates), a developmental pediatrician (to track milestones), as well as audiology/vision, sleep medicine, and gastroenterology specialists as needed [1].
  • Therapy Team: Speech-language pathologists (SLPs), occupational therapists (OTs), and physical therapists (PTs) are the backbone of daily support [5].
  • Support Services: Social workers and behavioral specialists can help navigate school services, insurance, and the emotional impact on your family [4][6].

Communication and Early Intervention

Severe language impairment is a hallmark of this condition, often involving a “plateau” or regression in speech [7]. Research emphasizes that speech and language therapy should begin as early as possible—as soon as a communication need is recognized, at any age [8].

  • Augmentative and Alternative Communication (AAC): If your child is minimally verbal, AAC is a critical tool. This can include anything from picture boards and signs to high-tech “talker” devices [9][10].
  • Debunking the Myth: Many parents worry that using a device will stop their child from learning to speak. Current research shows the opposite: AAC often supports functional communication and does not prevent the development of spoken words [9][11].
  • Tailored Goals: Communication therapy should focus on “functional” needs first—helping your child request what they want, say “no,” and express if they are in pain. Behavioral supports should always be communication-centered, non-aversive, and tailored to the child’s sensory needs [12][13].

Managing Physical and Functional Needs

Low muscle tone (hypotonia) and balance issues (ataxia) are common and can make moving through the world difficult [14].

  • Mobility Support: PTs focus on gait, balance, and safety. Your child may benefit from orthotics (braces) to stabilize their ankles or adaptive equipment like specialized strollers or walkers [5].
  • Fine Motor and Sensory: OTs help with hand strength and “activities of daily living,” such as dressing or using a spoon. They also help manage sensory processing needs, which are frequent in children with autism-like features [15][5].

Screening for Common Comorbidities

Children with DEEs often face additional health hurdles that require regular screening.

  • Sleep Disorders: Over 60% of children with DEEs experience sleep disruptions [16]. This includes insomnia (trouble falling or staying asleep) and obstructive sleep apnea, where breathing temporarily stops during sleep [17][18]. If you notice heavy snoring, gasping, or extreme daytime sleepiness, a referral for a sleep study (polysomnography) may be indicated.
  • Gastrointestinal (GI) Issues: Feeding and digestion problems are very common [19].
    • Feeding Difficulties: Hypotonia can affect the muscles used for chewing and swallowing (dysphagia). If a clinical assessment reveals coughing with meals, wet/gurgly breathing, or poor growth, an instrumental swallow study (like videofluoroscopy) may be ordered to check for aspiration [20][21].
    • GI Symptoms: Constipation, reflux, and a lack of interest in food (oral aversion) should be discussed with a specialist if they interfere with nutrition or comfort [19][22].

Holistic Quality of Life

Your child’s development is not just about therapy sessions; it is about participation in family and community life. Coordinated care that includes education and respite support for parents is not a luxury—it is a necessary part of managing a rare DEE [4][23]. By focusing on your child’s communication, comfort, and safety, you are building the strongest possible foundation for their future.

Common questions in this guide

What kind of care team does a child with CNTNAP2-related DEE need?
Care is usually coordinated across pediatric neurology, a genetics specialist, developmental pediatrics, and speech, occupational, and physical therapy. Sleep, gastrointestinal, audiology or vision, behavioral, social work, and school services may be added when needed.
Can AAC help my child communicate without delaying speech?
AAC includes picture boards, signs, and speech-generating devices for children who are minimally verbal or have difficulty expressing themselves. It can improve functional communication and does not prevent a child from developing spoken words.
Which therapies help with low muscle tone, balance, and daily activities?
Physical therapy can work on walking, balance, and safety, while occupational therapy can support hand skills, sensory needs, dressing, feeding tools, and other daily tasks. Braces or adaptive equipment may help some children move and participate more safely.
When should my child be evaluated for a sleep disorder?
Ask the care team about a sleep evaluation if your child snores heavily, gasps during sleep, has disrupted sleep, or is unusually sleepy during the day. A formal sleep study can check for problems such as obstructive sleep apnea.
What feeding or swallowing signs should prompt medical evaluation?
Coughing or gagging during meals, wet or gurgly breathing, feeding difficulty, or poor growth can signal a swallowing problem or food entering the airway. The care team may recommend a clinical assessment and, when appropriate, an instrumental swallow study such as videofluoroscopy.
How can we coordinate care and support our family?
A shared care plan can keep the neurologist, therapists, school team, and other specialists aligned on communication, safety, and daily goals. Social workers can help families find respite care, school resources, insurance support, and parent support groups.

Get notified when new evidence is published on CNTNAP2-related developmental and epileptic encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Beyond seizures: the hidden burden of developmental epileptic encephalopathies.

    Dell'Isola GB, Sorrentino M, Massara S, et al.

    Frontiers in neurology 2026; (17()):1960314 doi:10.3389/fneur.2026.1960314.

    PMID: 42953089
  2. 2

    Deciphering the concepts behind "Epileptic encephalopathy" and "Developmental and epileptic encephalopathy".

    Scheffer IE, Liao J

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2020; (24()):11-14 doi:10.1016/j.ejpn.2019.12.023.

    PMID: 31926847
  3. 3

    Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study.

    Essajee F, Urban M, Smit L, et al.

    Seizure 2022; (101()):197-204 doi:10.1016/j.seizure.2022.09.001.

    PMID: 36084525
  4. 4

    Real-world experience of diagnosis, disability, and daily management in parents of children with different genetic developmental and epileptic encephalopathies: a qualitative study.

    Garcia-Bravo C, Palacios-Ceña D, Aledo-Serrano Á, et al.

    Annals of medicine 2025; (57(1)):2446702 doi:10.1080/07853890.2024.2446702.

    PMID: 39731461
  5. 5

    SYNGAP1-related developmental and epileptic encephalopathy: The impact on daily life.

    Lo Barco T, De Gaetano L, Santangelo E, et al.

    Epilepsy & behavior : E&B 2022; (127()):108500 doi:10.1016/j.yebeh.2021.108500.

    PMID: 34954508
  6. 6

    Systematic review of indirect costs to families of children with developmental epileptic encephalopathies.

    Abdelmageed S, Du RY, Carroll M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):579 doi:10.1186/s13023-025-04081-9.

    PMID: 41225515
  7. 7

    CNTNAP2 in neurodevelopmental disorders: Genetics, excitation/inhibition mechanisms and preclinical evidence.

    Dhungel A, Bora R, Chamidah AN, Menge DM

    Molecular and cellular neurosciences 2026; (139()):104127 doi:10.1016/j.mcn.2026.104127.

    PMID: 42815598
  8. 8

    The epilepsy-autism phenotype associated with developmental and epileptic encephalopathies: New mechanism-based therapeutic options.

    Specchio N, Di Micco V, Aronica E, et al.

    Epilepsia 2025; (66(4)):970-987 doi:10.1111/epi.18209.

    PMID: 39985505
  9. 9

    Augmentative and Alternative Communication and Speech Production for Individuals with ASD: A Systematic Review.

    White EN, Ayres KM, Snyder SK, et al.

    Journal of autism and developmental disorders 2021; (51(11)):4199-4212 doi:10.1007/s10803-021-04868-2.

    PMID: 33511525
  10. 10

    Augmentative and Alternative Communication in an Elementary School Setting: A Case Study.

    Walker VL, Chung YC

    Language, speech, and hearing services in schools 2022; (53(1)):167-180 doi:10.1044/2021_LSHSS-21-00052.

    PMID: 34902289
  11. 11

    Parent-implemented augmented communication intervention and young children with Down syndrome: an exploratory report.

    Romski M, Sevcik RA, Barton-Hulsey A, et al.

    Frontiers in psychology 2023; (14()):1168599 doi:10.3389/fpsyg.2023.1168599.

    PMID: 37384179
  12. 12

    The effects of the DHACA method on expressive communication in children with autism spectrum disorder.

    Barbosa FCOL, Montenegro ACA, Queiroga BAM

    CoDAS 2025; (37(3)):e20240148 doi:10.1590/2317-1782/e20240148pt.

    PMID: 40197957
  13. 13

    Assessing Communication in Children with Complex Communication Needs: Development of the Italian IVCAA Structured Interview.

    Rinaldi S, Gazzola S, Maggiulli C, et al.

    Children (Basel, Switzerland) 2026; (13(8)) doi:10.3390/children13081051.

    PMID: 42650389
  14. 14

    Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum.

    Smogavec M, Cleall A, Hoyer J, et al.

    Journal of medical genetics 2016; (53(12)):820-827 doi:10.1136/jmedgenet-2016-103880.

    PMID: 27439707
  15. 15

    Learnings in developmental and epileptic encephalopathies: what do we know?

    Perinelli MG, Riva A, Amadori E, et al.

    Expert review of neurotherapeutics 2023; (23(1)):45-57 doi:10.1080/14737175.2023.2176221.

    PMID: 36726225
  16. 16

    Characterizing sleep disturbances in developmental and epileptic encephalopathies through natural language processing: A retrospective monocentric study.

    Barco TL, Douillet M, Chemaly N, et al.

    Epilepsia 2026; doi:10.1002/epi.70485.

    PMID: 42862603
  17. 17

    Sleep problems in Dravet syndrome: a modifiable comorbidity.

    Licheni SH, Mcmahon JM, Schneider AL, et al.

    Developmental medicine and child neurology 2018; (60(2)):192-198 doi:10.1111/dmcn.13601.

    PMID: 29110313
  18. 18

    Sleep and respiratory abnormalities in adults with developmental and epileptic encephalopathies using polysomnography and video-EEG monitoring.

    Sivathamboo S, Myers KA, Pattichis A, et al.

    Epilepsia open 2023; (8(3)):1157-1168 doi:10.1002/epi4.12772.

    PMID: 37277988
  19. 19

    Gastrointestinal Symptoms and Channelopathy-Associated Epilepsy.

    Beck VC, Isom LL, Berg AT

    The Journal of pediatrics 2021; (237()):41-49.e1 doi:10.1016/j.jpeds.2021.06.034.

    PMID: 34181986
  20. 20

    Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox-Gastaut syndrome, ESES: A functional framework.

    Berg AT, Gaebler-Spira D, Wilkening G, et al.

    Epilepsy & behavior : E&B 2020; (111()):107287 doi:10.1016/j.yebeh.2020.107287.

    PMID: 32759067
  21. 21

    Intrafamilial neurological phenotypic variability due to either biallelic or monoallelic pathogenic variants in CACNA1A.

    Mammadova D, Kraus C, Leis T, et al.

    Frontiers in neurology 2024; (15()):1458109 doi:10.3389/fneur.2024.1458109.

    PMID: 39416668
  22. 22

    SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy.

    Vlaskamp DRM, Shaw BJ, Burgess R, et al.

    Neurology 2019; (92(2)):e96-e107 doi:10.1212/WNL.0000000000006729.

    PMID: 30541864
  23. 23

    Psychological and health-related quality of life outcomes in children with developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS): A single-center prospective study.

    Sahu A, Sharma R, Lal G, Saini AG

    Epilepsy research 2026; (224()):107794 doi:10.1016/j.eplepsyres.2026.107794.

    PMID: 42008890

This page is for informational purposes only and does not constitute medical advice. Your child's pediatric neurology and therapy team should tailor developmental support and comorbidity screening to their needs.

Guide contents CNTNAP2-related developmental and epileptic encephalopathy
Research & Literature
04 Seizure Management & Medical Interventions 06 Long-Term Safety, Prognosis & Family Support